​

Cabaletta Bio Ownership | Who Owns Cabaletta Bio?

OverviewForecastFinancialsChart

Cabaletta Bio Ownership Summary

Cabaletta Bio is owned by 117.46% institutional investors, 1.65% insiders. Bain capital life sciences investors is the largest institutional shareholder, holding 15.64% of CABA shares. T. Rowe Price Small-Cap Value is the top mutual fund, with 3.96% of its assets in Cabaletta Bio shares.

CABA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCabaletta Bio117.46%1.65%-19.12%
SectorHealthcare Stocks 486.50%11.08%-397.59%
IndustryBiotech Stocks 304.14%11.08%-215.23%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bain capital life sciences investors9.68M15.64%$14.71M
Adage capital partners gp8.83M14.27%$13.42M
T. rowe price investment management6.79M10.98%$10.33M
Jennison associates6.02M9.73%$9.15M
Blackrock4.76M9.65%$35.58M
Cormorant asset management, lp5.00M8.08%$7.60M
Alyeska investment group4.80M7.76%$7.30M
Vanguard group2.87M5.86%$6.51M
Heights capital management3.14M5.08%$4.78M
Jefferies financial group2.00M3.23%$3.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Superstring capital management lp1.06M1.91%$1.61M
Bain capital life sciences investors9.68M1.84%$14.71M
Heights capital management3.14M1.28%$4.78M
Cormorant asset management, lp5.00M0.57%$7.60M
Blue owl capital lp1.13M0.55%$1.71M
Anson funds management lp1.82M0.40%$2.77M
Almitas capital367.49K0.14%$558.59K
Atika capital management1.00K0.07%$748.00K
Alyeska investment group4.80M0.03%$7.30M
Jefferies financial group2.00M0.03%$3.04M

Top Buyers

HolderShares% AssetsChange
Bain capital life sciences investors9.68M1.84%6.92M
Adage capital partners gp8.83M0.02%5.20M
Cormorant asset management, lp5.00M0.57%5.00M
Alyeska investment group4.80M0.03%4.80M
Jennison associates6.02M0.01%3.59M

Top Sellers

HolderShares% AssetsChange
Alkeon capital management---2.62M
Blackrock funding, inc. /de970.60K--2.48M
Vr adviser---1.56M
Sofinnova investments---1.53M
Stempoint capital lp---1.28M

New Positions

HolderShares% AssetsChangeValue
Cormorant asset management, lp5.00M0.57%5.00M$7.60M
Alyeska investment group4.80M0.03%4.80M$7.30M
Heights capital management3.14M1.28%3.14M$4.78M
Jefferies financial group2.00M0.03%2.00M$3.04M
Anson funds management lp1.82M0.40%1.82M$2.77M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-7.00
Gamma investing-12.00
Quantbot technologies lp-19.00
Bogart wealth-50.00
Rothschild investment-70.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202589-6.32%72,682,277102.25%1172.23%5019.05%27-20.59%
Mar 31, 202596-12.73%36,286,368-5.67%731.19%42-35.38%3545.83%
Dec 31, 202436-70.25%10,990,024-77.13%220.23%22-66.15%7-78.79%
Sep 30, 2024120-15.49%48,049,085-5.40%980.93%65-7.14%33-32.65%
Jun 30, 2024142-14.97%50,793,811-0.49%1030.96%70-21.35%492.08%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Small-Cap Value3.56M3.96%1.64M
Jennison Health Sciences Equity3.52M3.91%2.14M
PGIM Jennison Health Sciences Z3.52M3.85%-
Vanguard Total Stock Mkt Idx Inv2.56M2.80%-56.45K
Vanguard US Total Market Shares ETF1.40M2.76%-
Jennison SMid Cap Core Equity1.29M2.63%-
PGIM Jennison Small Company A1.29M2.63%-
T. Rowe Price U.S. SC Value Eq Tr-D2.10M2.33%1.04M
iShares Russell 2000 ETF1.17M2.31%-
T. Rowe Price Health Sciences1.94M2.16%1.63M

Recent Insider Transactions

DateNameRoleActivityValue
Jan 19, 2024Binder Gwendolyn See RemarksSell$14.23K
Jan 19, 2024Binder Gwendolyn See RemarksSell$201.21K
Dec 19, 2023Binder Gwendolyn See RemarksSell$171.20K
Dec 19, 2023Binder Gwendolyn See RemarksSell$69.59K
Nov 20, 2023Binder Gwendolyn See RemarksSell$61.61K

Insider Transactions Trends

DateBuySell
2025 Q2--
2025 Q1--
2024 Q2--
2024 Q1-2
2023 Q4-6

CABA Ownership FAQ

Who Owns Cabaletta Bio?

Cabaletta Bio shareholders are primarily institutional investors at 117.46%, followed by 1.65% insiders and -19.11% retail investors. The average institutional ownership in Cabaletta Bio's industry, Biotech Stocks , is 304.14%, which Cabaletta Bio falls below.

Who owns the most shares of Cabaletta Bio?

Cabaletta Bio’s largest shareholders are Bain capital life sciences investors (9.68M shares, 15.64%), Adage capital partners gp (8.83M shares, 14.27%), and T. rowe price investment management (6.79M shares, 10.98%). Together, they hold 40.89% of Cabaletta Bio’s total shares outstanding.

Does Blackrock own Cabaletta Bio?

Yes, BlackRock owns 9.65% of Cabaletta Bio, totaling 4.76M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.58M$. In the last quarter, BlackRock increased its holdings by 699.11K shares, a 17.23% change.

Who is Cabaletta Bio’s biggest shareholder by percentage of total assets invested?

Superstring capital management lp is Cabaletta Bio’s biggest shareholder by percentage of total assets invested, with 1.91% of its assets in 1.06M Cabaletta Bio shares, valued at 1.61M$.

Who is the top mutual fund holder of Cabaletta Bio shares?

T. Rowe Price Small-Cap Value is the top mutual fund holder of Cabaletta Bio shares, with 3.96% of its total shares outstanding invested in 3.56M Cabaletta Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools